title: Haplotypes of aldosterone synthase (CYP11B2) gene in the general population of Japan: the Ohasama study.
abstract: Since the identification of a chimeric aldosterone synthase which induces mendelian hypertension, polymorphisms in aldosterone synthase (CYP11B2) has been one of major targets for molecular analyses in association with hypertension. To date, four polymorphic variants of CYP11B2, -344T/C at promoter region, a gene conversion in intron 2, 2713A/G (in exon 3) which converts from Lys to Arg at codon 173 (K173R), and 4986T/C (in exon7) which converts from Val to Ala at codon 386 (V386A), have been identified in Caucasian population. Then, linkage disequilibrium between -344T/C polymorphism and a gene conversion in intron 2 or K173R mutation has been described, suggesting the presence of genetic haplotypes in Caucasians. Since the presence of a gene conversion in intron 2 or V386A mutation was still unknown in the Japanese population, all these polymorphisms were examined together to determine the CYP11B2 haplotypes of Japanese, using DNA samples from 1290 participants of the Ohasama study, who represent the general population of a rural community of northern Japan. Molecular analyses demon- strated the presence of a gene conversion of intron 2, but the absence of V386A mutation in Japanese population. The complete linkage disequilibrium between -344T/C polymorphism and K173R mutation was noted. Although -344T allele was linked either with a gene conversion in intron 2 or with normal intron 2, -344C allele was completely linked with normal intron 2. These results indicate the presence of 3 allelic haplotypes of CYP11B2, -344C with normal intron 2 and 173R, -344T with normal intron 2 and 173K, and -344T with converted intron 2 and 173K, in the general Japanese population. The frequency (total 1.0) was 0.35, 0.53, and 0.12, respectively. The presence of allelic haplotypes is considered to be an additional genetic information to individual polymorphism of CYP11B2 to determine the linkage between CYP11B2 polymorphisms and hypertension.
authors.affiliation: Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Medicine and Pharmaceutical Science, Sendai, Japan. mmitsu2i@mail.cc.tohoku.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Matsubara
authors.forename: F
authors.initials: F
authors.lastname: Omori
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.forename: H
authors.initials: H
authors.lastname: Metoki
authors.forename: M
authors.initials: M
authors.lastname: Kikuya
authors.forename: T
authors.initials: T
authors.lastname: Fujiwara
authors.forename: T
authors.initials: T
authors.lastname: Araki
authors.forename: Y
authors.initials: Y
authors.lastname: Imai
mesh_terms: D000328:Adult; D019405:Cytochrome P-450 CYP11B2 / Q000235:genetics*; D005785:Gene Conversion; D005828:Genetics, Population; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007438:Introns; D007564:Japan; D015810:Linkage Disequilibrium; D017354:Point Mutation; D011110:Polymorphism, Genetic; D012424:Rural Population
chemical_list: D019405:Cytochrome P-450 CYP11B2